LRRK2 and Parkinson disease: These findings were reproduced in a recent study showing that increased levels of leucine-rich repeat kinase 2 (LRRK2), which is involved in PD, enhanced tau neurotoxicity by stabilizing the actin cytoskeleton, promoting DRP1 mislocalization and mitochondrial elongation [137].